Trials / Sponsors / Mineralys Therapeutics Inc.
Mineralys Therapeutics Inc.
Industry · 6 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | A Study to Assess the Efficacy and Safety of Lorundrostat in Participants With Obstructive Sleep Apnea and Hyp Obstructive Sleep Apnea, Hypertension | Phase 2 | 2025-02-28 |
| Completed | Efficacy and Safety of Lorundrostat in Addition to Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Subje Chronic Kidney Disease | Phase 2 | 2023-12-14 |
| Completed | Efficacy and Safety of Lorundrostat in Subjects With Uncontrolled and Resistant Hypertension Hypertension | Phase 3 | 2023-11-22 |
| Active Not Recruiting | Open-Label Extension (OLE) Study to Assess Safety, Efficacy, and Tolerability of Lorundrostat in Subjects With Hypertension | Phase 3 | 2023-07-14 |
| Completed | A Pivotal Study to Evaluate the Efficacy of Lorundrostat in Subjects With Uncontrolled Hypertension on a Stand Hypertension | Phase 2 | 2023-03-13 |
| Completed | Trial on the Safety and Efficacy of MLS-101 in Patients With Uncontrolled Hypertension Hypertension, Renal | Phase 2 | 2021-07-01 |